← SynDRA
SALUBRINAL
SynDRA canonical compound SYN0005592 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EIF2S1 | SLC6A9 |
|---|
| Mechanism of action | eukaryotic translation initiation factor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- eukaryotic translation initiation factor inhibitor
Cross-references
Synonyms
- J8PSF5Z8KJ
- CHEBI:131923
- RefChem:884483
- DTXCID50832434
- MFCD00548612
- C21H17Cl3N4OS
- Salubrinal?
- eIF-2? Inhibitor
- UNII-J8PSF5Z8KJ
- orb1304594
- SCHEMBL6477826
- SCHEMBL17360638
- CHEBI:91873
- LCOIAYJMPKXARU-VAWYXSNFSA-N
- HMS3413G22
- HMS3677G22
- EX-A2153
- EBC-50076
- HB0573
- s2923
- STL253110
- AKOS000525027
- AKOS016042385
- CCG-269541
- NCGC00159554-01
- NCGC00159554-09
- AC-33176
- DA-67387
- NS-05839
- ST078198
- SW102000-2
- T3045
- C75050
- M03998
- BRD-A45107007-001-02-6
- BRD-A45107007-001-03-4
- BRD-A45107007-001-05-9
- BRD-A77299732-001-01-6
Look up SALUBRINAL in the interactive SynDRA portal →